| Assay ID | Title | Year | Journal | Article |
|---|
| AID1272865 | Inhibition of recombinant human CK2alpha using RRRDDDSDDD substrate peptide by scintillation counter in presence of [32P]ATP | 2016 | Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
| Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity. |
| AID1272882 | Cytotoxicity against human CCRF-CEM cells assessed as cell viability at 10 uM after 24 hrs by MTT assay | 2016 | Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
| Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity. |
| AID1272875 | Inhibition of CK1-alpha1 (unknown origin) assessed as enzyme activity at 10 uM | 2016 | Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
| Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity. |
| AID634716 | Inhibition of human CK2 alpha' catalytic subunit expressed in Escherichia coli BL21 (DE3) assessed as [33P]gamma-ATP incorporation into P2B substrate after 15 mins by scintillation counting | 2012 | European journal of medicinal chemistry, Jan, Volume: 47, Issue:1
| CK2Ī± and CK2Ī±' subunits differ in their sensitivity to 4,5,6,7-tetrabromo- and 4,5,6,7-tetraiodo-1H-benzimidazole derivatives. |
| AID634717 | Inhibition of human CK2 alpha' catalytic subunit expressed in Escherichia coli BE21 (DE3) assessed as [33P]gamma-ATP incorporation into RRRADDSDDDDD substrate after 15 mins by scintillation counting | 2012 | European journal of medicinal chemistry, Jan, Volume: 47, Issue:1
| CK2Ī± and CK2Ī±' subunits differ in their sensitivity to 4,5,6,7-tetrabromo- and 4,5,6,7-tetraiodo-1H-benzimidazole derivatives. |
| AID1272878 | Inhibition of HIPK1 (unknown origin) assessed as enzyme activity at 10 uM | 2016 | Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
| Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity. |
| AID1272893 | Induction of apoptosis in human CCRF-CEM cells assessed as late apoptotic cells at 50 uM after 24 hrs by annexinV and propidium iodide staining based FACS analysis (Rvb = 1.9 +/- 0.5%) | 2016 | Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
| Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity. |
| AID1623257 | Antiproliferative activity against rat C6 cells at 50 uM after 24 hrs by MTT assay relative to control | 2019 | European journal of medicinal chemistry, Feb-15, Volume: 164 | Recent advances in the discovery of small molecules targeting glioblastoma. |
| AID1272888 | Induction of apoptosis in human CCRF-CEM cells assessed as viable cells at 10 uM after 24 hrs by annexinV and propidium iodide staining based FACS analysis (Rvb = 96.4 +/- 1.2%) | 2016 | Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
| Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity. |
| AID1272886 | Cytotoxicity against human MCF7 cells assessed as cell viability at 20 uM after 24 hrs by MTT assay | 2016 | Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
| Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity. |
| AID634648 | Inhibition of human CK2 alpha catalytic subunit expressed in Escherichia coli BE21 (DE3) assessed as [33P]gamma-ATP incorporation into P2B substrate after 15 mins by scintillation counting | 2012 | European journal of medicinal chemistry, Jan, Volume: 47, Issue:1
| CK2Ī± and CK2Ī±' subunits differ in their sensitivity to 4,5,6,7-tetrabromo- and 4,5,6,7-tetraiodo-1H-benzimidazole derivatives. |
| AID634649 | Inhibition of human CK2 alpha catalytic subunit expressed in Escherichia coli BL21 (DE3) assessed as [33P]gamma-ATP incorporation into RRRADDSDDDDD substrate after 15 mins by scintillation counting | 2012 | European journal of medicinal chemistry, Jan, Volume: 47, Issue:1
| CK2Ī± and CK2Ī±' subunits differ in their sensitivity to 4,5,6,7-tetrabromo- and 4,5,6,7-tetraiodo-1H-benzimidazole derivatives. |
| AID696319 | Induction of apoptosis in human LNCAP cells assessed as PARP cleavage at 20 uM after 24 hrs by Western blot analysis | 2012 | Bioorganic & medicinal chemistry, Jul-15, Volume: 20, Issue:14
| Modified tetrahalogenated benzimidazoles with CK2 inhibitory activity are active against human prostate cancer cells LNCaP in vitro. |
| AID1420033 | Inhibition of DYRK1A (unknown origin) | 2018 | Journal of medicinal chemistry, 11-21, Volume: 61, Issue:22
| Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics. |
| AID281584 | Inhibition of CK2 | 2004 | Journal of medicinal chemistry, Dec-02, Volume: 47, Issue:25
| Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole. |
| AID634718 | Selectivity ratio of Ki for human CK2 alpha catalytic subunit to Ki for human CK2 alpha' catalytic subunit | 2012 | European journal of medicinal chemistry, Jan, Volume: 47, Issue:1
| CK2Ī± and CK2Ī±' subunits differ in their sensitivity to 4,5,6,7-tetrabromo- and 4,5,6,7-tetraiodo-1H-benzimidazole derivatives. |
| AID1272891 | Induction of apoptosis in human CCRF-CEM cells assessed as early apoptotic cells at 50 uM after 24 hrs by annexinV and propidium iodide staining based FACS analysis (Rvb = 1.5 +/- 0.8%) | 2016 | Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
| Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity. |
| AID1393964 | Antiproliferative activity against human CCRF-CEM cells assessed as cell viability at 50 uM after 72 hrs by MTT assay | 2018 | European journal of medicinal chemistry, Apr-25, Volume: 150 | Synthesis of novel proxyphylline derivatives with dual Anti-Candida albicans and anticancer activity. |
| AID1393966 | Antiproliferative activity against human CCRF-CEM cells assessed as cell viability at 200 uM after 72 hrs by MTT assay | 2018 | European journal of medicinal chemistry, Apr-25, Volume: 150 | Synthesis of novel proxyphylline derivatives with dual Anti-Candida albicans and anticancer activity. |
| AID1272880 | Inhibition of PKA (unknown origin) assessed as enzyme activity at 10 uM | 2016 | Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
| Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity. |
| AID1272889 | Induction of apoptosis in human CCRF-CEM cells assessed as viable cells at 50 uM after 24 hrs by annexinV and propidium iodide staining based FACS analysis (Rvb = 96.4 +/- 1.2%) | 2016 | Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
| Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity. |
| AID696313 | Antiproliferative activity against human LNCAP cells assessed as decrease in cell viability at 20 uM after 48 hrs by MTT assay | 2012 | Bioorganic & medicinal chemistry, Jul-15, Volume: 20, Issue:14
| Modified tetrahalogenated benzimidazoles with CK2 inhibitory activity are active against human prostate cancer cells LNCaP in vitro. |
| AID1272876 | Inhibition of DYRK1A (unknown origin) assessed as enzyme activity at 10 uM | 2016 | Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
| Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity. |
| AID1393968 | Antiproliferative activity against human MCF7 cells assessed as cell viability at 50 uM after 72 hrs by MTT assay | 2018 | European journal of medicinal chemistry, Apr-25, Volume: 150 | Synthesis of novel proxyphylline derivatives with dual Anti-Candida albicans and anticancer activity. |
| AID1393969 | Antiproliferative activity against human MCF7 cells assessed as cell viability at 100 uM after 72 hrs by MTT assay | 2018 | European journal of medicinal chemistry, Apr-25, Volume: 150 | Synthesis of novel proxyphylline derivatives with dual Anti-Candida albicans and anticancer activity. |
| AID1272897 | Inhibition of CK2 in human MCF7 cells assessed as decrease in phosphorylation of p65 at S529 residue after 48 hrs by immunoblot analysis | 2016 | Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
| Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity. |
| AID1272892 | Induction of apoptosis in human CCRF-CEM cells assessed as late apoptotic cells at 10 uM after 24 hrs by annexinV and propidium iodide staining based FACS analysis (Rvb = 1.9 +/- 0.5%) | 2016 | Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
| Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity. |
| AID1272895 | Induction of apoptosis in human CCRF-CEM cells assessed as necrotic cells at 50 uM after 24 hrs by annexinV and propidium iodide staining based FACS analysis (Rvb = 0.1 +/- 0.1%) | 2016 | Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
| Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity. |
| AID1393963 | Antiproliferative activity against human CCRF-CEM cells assessed as cell viability at 25 uM after 72 hrs by MTT assay | 2018 | European journal of medicinal chemistry, Apr-25, Volume: 150 | Synthesis of novel proxyphylline derivatives with dual Anti-Candida albicans and anticancer activity. |
| AID1272874 | Inhibition of CDK2/CycA2 (unknown origin) assessed as enzyme activity at 10 uM | 2016 | Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
| Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity. |
| AID1272894 | Induction of apoptosis in human CCRF-CEM cells assessed as necrotic cells at 10 uM after 24 hrs by annexinV and propidium iodide staining based FACS analysis (Rvb = 0.1 +/- 0.1%) | 2016 | Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
| Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity. |
| AID1272881 | Inhibition of PRKD2 (unknown origin) assessed as enzyme activity at 10 uM | 2016 | Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
| Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity. |
| AID1272885 | Cytotoxicity against human MCF7 cells assessed as cell viability at 10 uM after 24 hrs by MTT assay | 2016 | Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
| Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity. |
| AID1272879 | Inhibition of PIM1 (unknown origin) assessed as enzyme activity at 10 uM | 2016 | Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
| Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity. |
| AID1272883 | Cytotoxicity against human CCRF-CEM cells assessed as cell viability at 20 uM after 24 hrs by MTT assay | 2016 | Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
| Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity. |
| AID1272884 | Cytotoxicity against human CCRF-CEM cells assessed as cell viability at 50 uM after 24 hrs by MTT assay | 2016 | Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
| Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity. |
| AID1393965 | Antiproliferative activity against human CCRF-CEM cells assessed as cell viability at 100 uM after 72 hrs by MTT assay | 2018 | European journal of medicinal chemistry, Apr-25, Volume: 150 | Synthesis of novel proxyphylline derivatives with dual Anti-Candida albicans and anticancer activity. |
| AID1539763 | Inhibition of CK2alpha in human PLC1 cells using (Arg)3(Glu)3Thr(Glu)3 as substrate after 24 hrs in presence of [32P]gammaGTP | 2019 | European journal of medicinal chemistry, Nov-01, Volume: 181 | Small molecule modulators targeting protein kinase CK1 and CK2. |
| AID1362778 | Displacement of 5-TAMRA-labeled ARC-1530 from CK2alpha (unknown origin) (1 to 335 residues) after 15 to 60 mins by luminescence assay | 2018 | Bioorganic & medicinal chemistry, 10-01, Volume: 26, Issue:18
| Thiazole- and selenazole-comprising high-affinity inhibitors possess bright microsecond-scale photoluminescence in complex with protein kinase CK2. |
| AID696310 | Inhibition of CK2 in human LNCAP cell lysate using RRRDDDSDDD as substrate assessed as residual activity at 10 to 20 uM after 24 hrs by [32P]incorporation-based scintillation counting | 2012 | Bioorganic & medicinal chemistry, Jul-15, Volume: 20, Issue:14
| Modified tetrahalogenated benzimidazoles with CK2 inhibitory activity are active against human prostate cancer cells LNCaP in vitro. |
| AID1393970 | Antiproliferative activity against human MCF7 cells assessed as cell viability at 200 uM after 72 hrs by MTT assay | 2018 | European journal of medicinal chemistry, Apr-25, Volume: 150 | Synthesis of novel proxyphylline derivatives with dual Anti-Candida albicans and anticancer activity. |
| AID393020 | Inhibition of human recombinant casein kinase 2 subunit alpha expressed in Escherichia coli BL21 (DE3) assessed as [32P] incorporation by liquid scintillation counting | 2009 | Bioorganic & medicinal chemistry, Feb-15, Volume: 17, Issue:4
| Synthesis of new analogs of benzotriazole, benzimidazole and phthalimide--potential inhibitors of human protein kinase CK2. |
| AID696312 | Antiproliferative activity against human LNCAP cells assessed as decrease in cell viability at 10 uM after 48 hrs by MTT assay | 2012 | Bioorganic & medicinal chemistry, Jul-15, Volume: 20, Issue:14
| Modified tetrahalogenated benzimidazoles with CK2 inhibitory activity are active against human prostate cancer cells LNCaP in vitro. |
| AID1272890 | Induction of apoptosis in human CCRF-CEM cells assessed as early apoptotic cells at 10 uM after 24 hrs by annexinV and propidium iodide staining based FACS analysis (Rvb = 1.5 +/- 0.8%) | 2016 | Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
| Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity. |
| AID1272877 | Inhibition of Erk1 (unknown origin) assessed as enzyme activity at 10 uM | 2016 | Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
| Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity. |
| AID1272896 | Inhibition of CK2 in human CCRF-CEM cells assessed as decrease in phosphorylation of p65 at S529 residue after 48 hrs by immunoblot analysis | 2016 | Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
| Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity. |
| AID452301 | Inhibition of rat liver Casein kinase 2 | 2009 | Bioorganic & medicinal chemistry, Oct-15, Volume: 17, Issue:20
| Tetraiodobenzimidazoles are potent inhibitors of protein kinase CK2. |
| AID393021 | Inhibition of human recombinant casein kinase 2 subunit alpha2beta2 expressed in Escherichia coli BL21 (DE3) assessed as [32P] incorporation by liquid scintillation counting | 2009 | Bioorganic & medicinal chemistry, Feb-15, Volume: 17, Issue:4
| Synthesis of new analogs of benzotriazole, benzimidazole and phthalimide--potential inhibitors of human protein kinase CK2. |
| AID1272887 | Cytotoxicity against human MCF7 cells assessed as cell viability at 50 uM after 24 hrs by MTT assay | 2016 | Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
| Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity. |
| AID1393967 | Antiproliferative activity against human MCF7 cells assessed as cell viability at 25 uM after 72 hrs by MTT assay | 2018 | European journal of medicinal chemistry, Apr-25, Volume: 150 | Synthesis of novel proxyphylline derivatives with dual Anti-Candida albicans and anticancer activity. |
| AID1293266 | Inhibition of human wild type CK2alpha | 2016 | Journal of medicinal chemistry, Mar-10, Volume: 59, Issue:5
| Computational Tools To Model Halogen Bonds in Medicinal Chemistry. |
| AID1508630 | Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay | 2021 | Cell reports, 04-27, Volume: 35, Issue:4
| A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. |
| AID1347412 | qHTS assay to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: Counter screen cell viability and HiBit confirmation | 2020 | ACS chemical biology, 07-17, Volume: 15, Issue:7
| High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle. |
| AID1347405 | qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS LOPAC collection | 2020 | ACS chemical biology, 07-17, Volume: 15, Issue:7
| High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle. |
| AID1347045 | Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot counterscreen GloSensor control cell line | 2019 | Science translational medicine, 07-10, Volume: 11, Issue:500
| Inhibition of natriuretic peptide receptor 1 reduces itch in mice. |
| AID1347086 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID1347151 | Optimization of GU AMC qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
| Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
| AID1347050 | Natriuretic polypeptide receptor (hNpr2) antagonism - Pilot subtype selectivity assay | 2019 | Science translational medicine, 07-10, Volume: 11, Issue:500
| Inhibition of natriuretic peptide receptor 1 reduces itch in mice. |
| AID1347082 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID1347049 | Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot screen | 2019 | Science translational medicine, 07-10, Volume: 11, Issue:500
| Inhibition of natriuretic peptide receptor 1 reduces itch in mice. |
| AID1347058 | CD47-SIRPalpha protein protein interaction - HTRF assay qHTS validation | 2019 | PloS one, , Volume: 14, Issue:7
| Quantitative high-throughput screening assays for the discovery and development of SIRPĪ±-CD47 interaction inhibitors. |
| AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID504836 | Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation | 2002 | The Journal of biological chemistry, Apr-19, Volume: 277, Issue:16
| Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells. |
| AID588349 | qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay | | | |
| AID1347059 | CD47-SIRPalpha protein protein interaction - Alpha assay qHTS validation | 2019 | PloS one, , Volume: 14, Issue:7
| Quantitative high-throughput screening assays for the discovery and development of SIRPĪ±-CD47 interaction inhibitors. |
| AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID1347057 | CD47-SIRPalpha protein protein interaction - LANCE assay qHTS validation | 2019 | PloS one, , Volume: 14, Issue:7
| Quantitative high-throughput screening assays for the discovery and development of SIRPĪ±-CD47 interaction inhibitors. |
| AID1347083 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID1347410 | qHTS for inhibitors of adenylyl cyclases using a fission yeast platform: a pilot screen against the NCATS LOPAC library | 2019 | Cellular signalling, 08, Volume: 60 | A fission yeast platform for heterologous expression of mammalian adenylyl cyclases and high throughput screening. |
| AID588378 | qHTS for Inhibitors of ATXN expression: Validation | | | |
| AID1811 | Experimentally measured binding affinity data derived from PDB | 2007 | Chembiochem : a European journal of chemical biology, Oct-15, Volume: 8, Issue:15
| The ATP-binding site of protein kinase CK2 holds a positive electrostatic area and conserved water molecules. |
| AID977610 | Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB | 2007 | Chembiochem : a European journal of chemical biology, Oct-15, Volume: 8, Issue:15
| The ATP-binding site of protein kinase CK2 holds a positive electrostatic area and conserved water molecules. |
| AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | 2014 | Journal of biomolecular screening, Jul, Volume: 19, Issue:6
| A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum. |
| AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | | | |
| AID1802603 | CK2α Inhibition Assay from Article 10.1016/j.bioorg.2017.02.017: \\Synthesis, in vitro antiproliferative activity and kinase profile of new benzimidazole and benzotriazole derivatives.\\ | 2017 | Bioorganic chemistry, 06, Volume: 72 | Synthesis, in vitro antiproliferative activity and kinase profile of new benzimidazole and benzotriazole derivatives. |
| AID1801065 | Inhibition of Steady-State Catalysis Assay from Article 10.1021/bi500959t: \\Quinone reductase 2 is an adventitious target of protein kinase CK2 inhibitors TBBz (TBI) and DMAT.\\ | 2015 | Biochemistry, Jan-13, Volume: 54, Issue:1
| Quinone reductase 2 is an adventitious target of protein kinase CK2 inhibitors TBBz (TBI) and DMAT. |
| AID1801064 | Fluorescence Titration Assay from Article 10.1021/bi500959t: \\Quinone reductase 2 is an adventitious target of protein kinase CK2 inhibitors TBBz (TBI) and DMAT.\\ | 2015 | Biochemistry, Jan-13, Volume: 54, Issue:1
| Quinone reductase 2 is an adventitious target of protein kinase CK2 inhibitors TBBz (TBI) and DMAT. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |